These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1563579)

  • 1. Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus.
    Kortlandt W; Benschop C; van Rijn HJ; Erkelens DW
    Diabetologia; 1992 Mar; 35(3):202-7. PubMed ID: 1563579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?
    Moro E; Alessandrini P; Zambon C; Pianetti S; Pais M; Cazzolato G; Bon GB
    Diabet Med; 1999 Aug; 16(8):663-9. PubMed ID: 10477211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin deficiency on low density lipoprotein metabolism in rabbits.
    Golay A; Zech L; Shi MZ; Chiou YA; Reaven GM; Chen YD
    Horm Metab Res; 1988 Jan; 20(1):11-4. PubMed ID: 3286445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
    De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
    Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys.
    Litwak KN; Cefalu WT; Wagner JD
    Metabolism; 1998 Aug; 47(8):947-54. PubMed ID: 9711990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.
    Reaven PD; Herold DA; Barnett J; Edelman S
    Diabetes Care; 1995 Jun; 18(6):807-16. PubMed ID: 7555507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency.
    Bucala R; Makita Z; Vega G; Grundy S; Koschinsky T; Cerami A; Vlassara H
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9441-5. PubMed ID: 7937786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein abnormalities in well-treated type II diabetic patients.
    Manzato E; Zambon A; Lapolla A; Zambon S; Braghetto L; Crepaldi G; Fedele D
    Diabetes Care; 1993 Feb; 16(2):469-75. PubMed ID: 8432219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes.
    Rosenstock J; Vega GL; Raskin P
    Diabetes; 1988 Apr; 37(4):393-7. PubMed ID: 3288528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum glycated lipoproteins in type II diabetic patients with and without complications.
    Yeğin A; Ozben T
    Ann Clin Biochem; 1995 Sep; 32 ( Pt 5)():459-63. PubMed ID: 8830620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.
    Goldberg IJ; Hu Y; Noh HL; Wei J; Huggins LA; Rackmill MG; Hamai H; Reid BN; Blaner WS; Huang LS
    Diabetes; 2008 Jun; 57(6):1674-82. PubMed ID: 18346984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitus.
    Stolinski M; Alam S; Jackson NC; Shojaee-Moradie F; Pentecost C; Jefferson W; Christ ER; Jones RH; Umpleby AM
    Metabolism; 2008 Nov; 57(11):1608-14. PubMed ID: 18940401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.
    Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ
    Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptozotocin- and alloxan-induced diabetes modifies total plasma and lipoprotein lipid concentration and composition without altering cholesteryl ester transfer activity.
    Wasan KM; Ng SP; Wong W; Rodrigues BB
    Pharmacol Toxicol; 1998 Oct; 83(4):169-75. PubMed ID: 9820878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes.
    Koba S; Hirano T; Yoshino G; Sakai K; Sakaue T; Adachi M; Katagiri T
    Atherosclerosis; 2002 Jan; 160(1):249-56. PubMed ID: 11755944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glycation of low-density lipoprotein on the immunological determination of apolipoprotein B.
    Press RD; Wilding P
    Clin Chem; 1989 Nov; 35(11):2219-23. PubMed ID: 2582619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
    Julier K; Mackness MI; Dean JD; Durrington PN
    Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turnover of 125I-VLDL and 131I-LDL apolipoprotein B in rabbits fed diets containing casein or soy protein.
    Khosla P; Samman S; Carroll KK; Huff MW
    Biochim Biophys Acta; 1989 Apr; 1002(2):157-63. PubMed ID: 2930765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.